Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter

Journal of Neuropathology and Experimental Neurology

Volumn 68, Issue 5, 2009, Pages 489-502

  Vercellino, Marco ^a   Masera, Silvia ^a   Lorenzatti, Marcella ^a   Condello, Cecilia ^a   Merola, Aristide ^a   Mattioda, Alessandra ^a   Tribolo, Antonella ^a   Capello, Elisabetta ^b   Mancardi, Giovanni Luigi ^b   Mutani, Roberto ^a   Giordana, Maria Teresa ^a   Cavalla, Paola ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Basal ganglia; Caudate; Excitotoxicity; Gray matter; Multiple sclerosis; Neuronal loss; Thalamus

Indexed keywords

MYELIN; FIBRINOGEN; HLA DR ANTIGEN; LEUKOCYTE ANTIGEN; MYELIN BASIC PROTEIN; NERVE PROTEIN;

ADULT; AGED; AMYGDALOID NUCLEUS; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ATROPHY; AXONAL INJURY; BRAIN; BRAIN DAMAGE; BRAIN SLICE; CAUDATE NUCLEUS; CELL LOSS; CLAUSTRUM; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP GRAY MATTER; DEMYELINATION; DISEASE COURSE; FEMALE; GLOBUS PALLIDUS; GRAY MATTER; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MALE; MICROGLIA; MORPHOMETRICS; MULTIPLE SCLEROSIS; NERVE CELL; NERVE CELL ATROPHY; NERVE DEGENERATION; PRIORITY JOURNAL; PUTAMEN; SUBSTANTIA NIGRA; THALAMUS; WHITE MATTER; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; GLIA; METABOLISM; MIDDLE AGED; PATHOLOGY; STAINING;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIGENS, CD; BRAIN; DEMYELINATING DISEASES; FEMALE; FIBRINOGEN; HLA-DR ANTIGENS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NEUROGLIA; NEURONS; STAINING AND LABELING;

EID: 70149124713     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3181a19a5a     Document Type: Article

References (51)

1. Peterson JW, BL L, Mork S, et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001;50:389-400
2. BL L, Vedeler CA, Nyland HI, et al. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003;62:723-732
3. Vercellino M, Plano F, Votta B, et al. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 2005;64:1101-1107
4. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelina-tion and diffuse white matter injury in multiple sclerosis. Brain 2005; 128:2705-2712
5. Kutzelnigg A, Faber-Rod JC, Bauer J, et al. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 2007;17:38-44
6. Gilmore CP, BL L, Owens T, et al. Spinal cord gray matter demyelination in multiple sclerosisVa novel pattern of residual plaque morphology. Brain Pathol 2006;16:202-208
7. Geurts JJ, BL L, Roosendaal SD, et al. Extensive hippocampal demyelination in multiple sclerosis. J Neuropathol Exp Neurol 2007; 66:819-827
8. Papadopoulos D, Dukes S, Patel R, et al. Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis. Brain Pathol 2008 [Epub ahead of print]
9. Geurts JJ, BL L, Pouwels PJ, et al. Cortical lesions in multiple sclerosis: Combined postmortem MR imaging and histopathology. Am J Neuroradiol 2005;26:572-577
10. Geurts JJ, Blezer EL, Vrenken H, et al. Does high-field MR imaging improve cortical lesion detection in multiple sclerosis? J Neurol 2008; 255:183-191
11. BL L, Vedeler CA, Nyland H, et al. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 2003;9:323-331
12. Brink BP, Veerhuis R, Breij ECW, et al. The pathology of multiple sclerosis is location-dependent: No significant complement activation is detected in purely cortical lesions. J Neuropathol Exp Neurol 2005;64: 147-155
13. Van Horssen J, Brink BP, de Vries HE, et al. The blood-brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol 2007;66: 321-328
14. Bermel RA, Innus MD, Tjoa CW, et al. Selective caudate atrophy in multiple sclerosis: A 3D MRI parcellation study. Neuroreport 2003;14: 335-339
15. Prinster A, Quarantelli M, Orefice G, et al. Grey matter loss in relapsing-remitting multiple sclerosis: A voxel-based morphometry study. Neuroimage 2006;29:859-867
16. Mesaros S, Rocca MA, Absinta M, et al. Evidence of thalamic gray matter loss in pediatric multiple sclerosis. Neurology 2008;70:1107-1112
17. Houtchens MK, Benedict RH, Killiany R, et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007;69:1213-1223
18. Wylezinska M, Cifelli A, Jezzard P, et al. Thalamic neurodegeneration in relapsing-remitting multiple sclerosis. Neurology 2003;60:1949-1954
19. Cifelli A, Arridge M, Jezzard P, et al. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002;52:650-653
20. Geurts JJ, Reuling IE, Vrenken H, et al. MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis. Magn Reson Med 2006;55:478-483
21. Henry RG, Shieh M, Okuda DT, et al. Regional grey matter atrophy in clinically isolated syndromes at presentation. J Neurol Neurosurg Psychiatry 2008;79:1236-1244
22. Sepulcre J, Sastre-Garriga J, Cercignani M, et al. Regional gray matter atrophy in early primary progressive multiple sclerosis: A voxel-based morphometry study. Arch Neurol 2006;63:1175-1180
23. BL L, Mö rk S, Kong PA, et al. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 1994;51: 135-146
24. Van der Valk P, De Groot CJ. Staging of multiple sclerosis (MS) lesions: Pathology of the time frame of MS. Neuropathol Appl Neurobiol 2000; 26:2-10
25. Abercrombie M. Estimation of nuclear population from microtome sections. Anat Rec A Discov Mol Cell Evol Biol 1946;94:239-247
26. Law AJ, Harrison PJJ. The distribution and morphology of prefrontal cortex pyramidal neurons identified using anti-neurofilament antibodies SMI32, N200 and FNP7. Normative data and a comparison in subjects with schizophrenia, bipolar disorder or major depression. Psychiatr Res 2003;37:487-499
27. Glantz LA, Lewis DA. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch Gen Psychiatry 1997;54:943-952
28. Masliah E, Terry RD, Alford M, et al. Quantitative immunohistochemistry of synaptophysin in human neocortex: An alternative method to estimate density of presynaptic terminals in paraffin sections. J Histochem Cytochem 1990;38:837-844
29. Masliah E, Terry RD, Alford M, et al. Cortical and subcortical patterns of synaptophysin-like immunoreactivity in Alzheimer's disease. Am J Pathol 1991;138:235-246
30. Vercellino M, Merola A, Piacentino C. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: Correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J Neuropathol Exp Neurol 2007;66: 732-739
31. Danbolt NC. Glutamate uptake. Progr Neurobiol 2001;65:1-105
32. Rothstein JD, Dykes-Hoberg M, Pardo CA, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996;16:675-686
33. Domercq M, Etxebarria E, Perez-Samartin A, Matute C. Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition. Glia 2005;52:36-46
34. Ye ZC, Sontheimer H. Cytokine modulation of glial glutamate uptake: A possible involvement of nitric oxide. Neuroreport 1996;7:2181-2185
35. Trotti D, Rossi D, Gjesdal O, et al. Peroxynitrite inhibits glutamate transporter subtypes. J Biol Chem 1996;271:5976-5979
36. Ohgoh M, Hanada T, Smith T, et al. Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis. J Neuroimmunol 2002;125:170-178
37. Levi G, Patrizio M. Glutamate production by cultured microglia: Differences between rat and mouse, enhancement by lipopolysaccharide and lack effect of HIV coat protein gp120 and depolarizing agents. Neurosci Lett 1994;178:184-188
38. Werner P, Pitt D, Raine CS. Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocytes and axonal damage. Ann Neurol 2001;50:169-180
39. Vermeiren C, Najimi M, Vanhoutte N, et al. Acute up-regulation of glutamate uptake mediated by mGluR5a in reactive astrocytes. J Neurochem 2005;94:405-416
40. Mott RT, Ait-Ghezala G, Town T, et al. Neuronal expression of CD22: Novel mechanism for inhibiting microglial proinflammatory cytokine production. Glia 2004;46:369-379
41. Hoek RM, Ruuls SR, Murphy CA, et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000;290:1768-1771
42. Chitnis T, Imitola J, Wang Y, et al. Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration. Am J Pathol 2007;170:1695-1712
43. Meuth SG, Simon OJ, Grimm A, et al. CNS inflammation and neuronal degeneration is aggravated by impaired CD200-CD200RYmediated macrophage silencing. J Neuroimmunol 2008;194:62-69
44. Liu Y, Teige I, Birnir B, et al. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat Med 2006; 12:518-525
45. Wegner C, Esiri MM, Chance SA, et al. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 2006;67:960-967
46. Gray E, Thomas TL, Betmouni S, et al. Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis. Brain Pathol 2008;18:86-95
47. Egan DA, Flumerfelt BA, Gwyn DG. Axon reaction in the red nucleus of the rat. Perikaryal volume changes and the time course of chromatolysis following cervical and thoracic lesions. Acta Neuropathol 1977;37:13-19
48. Ginsberg SD, Martin LJ. Axonal transection in adult rat brain induces transsynaptic apoptosis and persistent atrophy of target neurons. J Neurotrauma 2002;19:99-109
49. Nociti V, Bentivoglio AR, Frisullo G, et al. Movement disorders in multiple sclerosis: Causal or coincidental association? Mult Scler 2008; 14:1284-1287
50. Benedict RH, Weinstock-Guttman B, Fishman I, et al. Prediction of neuropsychological impairment in multiple sclerosis: Comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004;61:226-230
51. Inglese M, Park SJ, Johnson G, et al. Deep gray matter perfusion in multiple sclerosis: Dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. Arch Neurol 2007;64:196-202 (Pubitemid 46256559)